Nanocarriers for siRNA delivery to overcome cancer multidrug resistance

被引：0
|
作者：
MENG QingShuo [1 ]
YIN Qi [1 ]
LI YaPing [1 ]
机构：
[1] Center of Pharmaceutics,Shanghai Institute of Materia Medica,Chinese Academy of Sciences
来源：
Science Bulletin | 2013年 / 33期
基金：
中国国家自然科学基金;
关键词：
cationic polymers; inorganic carriers; liposomes; multidrug resistance; nanocarriers; siRNA delivery;
D O I：
暂无
中图分类号：
R730.5 [肿瘤治疗学];
学科分类号：
100214 ;
摘要：
Multidrug resistance(MDR)is an extremely complexed phenomenon in tumor chemotherapy and is one of the major obstacles for successful treatment.Discovery of RNA interference(RNAi)offers a new strategy with great potential to reverse MDR.Specific genes,which contribute to the emerging of MDR,can be silenced by RNAi.However,many natural barriers have to be overcome for efficient and safe delivery of siRNA.In recent years,the various kinds of nanocarriers,such as liposomes,cationic polymers,and inorganic materials,have been developed to deliver siRNA and show good results in reversing MDR.This review mainly summarizes the barriers in siRNA delivery and recent progress in designing nanotechnology-based siRNA delivery systems to overcome tumor MDR.
引用
收藏
页码：4021 / 4030
页数：10
相关论文
共 50 条
  • [21] Natural Product Modulators to Overcome Multidrug Resistance In Cancer
    Cort, Aysegul
    Ozben, Tomris
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2015, 67 (03): : 411 - 423
  • [22] Engineering Nanomedicines to Overcome Multidrug Resistance in Cancer Therapy
    Beretta, Giovanni L.
    Cavalieri, Francesca
    CURRENT MEDICINAL CHEMISTRY, 2016, 23 (01) : 3 - 22
  • [23] Stealth monoolein-based nanocarriers for delivery of siRNA to cancer cells
    Oliveira, Ana C. N.
    Raemdonck, Koen
    Martens, Thomas
    Rombouts, Koen
    Simon-Vazquez, Rosana
    Botelho, Claudia
    Lopes, Ivo
    Lucio, Marlene
    Gonzalez-Fernandez, Africa
    Real Oliveira, M. Elisabete C. D.
    Gomes, Andreia C.
    Braeckmans, Kevin
    ACTA BIOMATERIALIA, 2015, 25 : 216 - 229
  • [24] Recent advances in siRNA delivery for cancer therapy using smart nanocarriers
    Zhang, Penghui
    An, Keli
    Duan, Xiaoman
    Xu, Hao
    Li, Fei
    Xu, Feng
    DRUG DISCOVERY TODAY, 2018, 23 (04) : 900 - 911
  • [25] Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents
    Zhao, Jing
    Feng, Si-Shen
    NANOMEDICINE, 2015, 10 (14) : 2199 - 2228
  • [26] Targeted multidrug delivery system to overcome chemoresistance in breast cancer
    Tang, Yuan
    Soroush, Fariborz
    Tong, Zhaohui
    Kiani, Mohammad F.
    Wang, Bin
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2017, 12 : 671 - 681
  • [27] Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer
    Tonbul, Hayrettin
    Sahin, Adem
    Tavukcuoglu, Ece
    Esendagli, Gunes
    Capan, Yilmaz
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2019, 54
  • [28] siRNA Delivery by Stimuli-Sensitive Nanocarriers
    Salzano, Giuseppina
    Costa, Daniel F.
    Torchilin, Vladimir P.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (31) : 4566 - 4573
  • [29] A targeted nanoplatform co-delivery of pooled siRNA and doxorubicin for reversing of multidrug resistance in breast cancer
    Liu, Hongmei
    Ma, Ding
    Chen, Jinpeng
    Ye, Li
    Li, Yiping
    Xie, Yuexia
    Zhao, Xue
    Zou, Hanbing
    Chen, Xiaojing
    Pu, Jun
    Liu, Peifeng
    NANO RESEARCH, 2022, 15 (07) : 6306 - 6314
  • [30] A targeted nanoplatform co-delivery of pooled siRNA and doxorubicin for reversing of multidrug resistance in breast cancer
    Hongmei Liu
    Ding Ma
    Jinpeng Chen
    Li Ye
    Yiping Li
    Yuexia Xie
    Xue Zhao
    Hanbing Zou
    Xiaojing Chen
    Jun Pu
    Peifeng Liu
    Nano Research, 2022, 15 : 6306 - 6314
12345